Moreover, a strong association between PGRMC1 over-expression and worse overall survival of breast cancer (Muranen et al., 2011), acute myelocytic leukemia (Wouters et al., 2009), and sarcoma patients (Savola et al., 2011) was also observed (Figure 3C). Here, PGRMC1 is linked to breast carcinoma.